A growing number of scientific investigators are evaluating the potential of psychedelic drugs to open a new field of medicinal solutions, particularly in response to chronic health conditions with unmet needs to be solved. A number of legislators are getting on board and venture capital investment in the psychedelics sector is rising explosively, recording $329 million during the first four months of 2021 alone (https://www.nnw.fm/HsIZv).
Conference event series organizer Microdose sponsors virtual gatherings each month to address the newest opportunities and deepest insights in the psychedelic industry, covering the top companies and the latest IPOs. Microdose’s Psychedelics Capital conference series recently observed its annual birthday and will next take place Aug. 31 in an online format set to begin at 1:30 p.m EDT but accessible from anywhere in the world. Mobile users can access the event via iOS and Android apps; up-to-date Chrome and Firefox browsers are preferred for desktop access.
The conferences provide participants opportunities to network and ask questions as well as to learn from the presenters, and recordings of the presentations will be made available to the participants afterward on a lifetime basis. Recent conferences have included not only presentations on varied products, but insights on the expanding psychedelic pharmaceutical sector. Investors as well as attendees interested in the opportunities the field portends will be able to learn from a curated group of CEOs, capital advisors and investment luminaries from around the world.
For tickets, visit the event’s website at microdose.buzz